407 Squire Rd,

Revere,

MA,

US,

ZIP: 02151

Phone: +1 617 455 4188

Skin microbiome research is continuing to gain increasing market traction from a number of stakeholders, including drug developers and cosmetic brands. For investment and progress to continue, it is vital to meet and connect with the key opinion leaders in the space.

Now in its fifth year, the Microbiome Movement – Skin Health & Dermatology Summit will unite the field’s leaders from academia and industry to address the unique scientific and commercial challenges of working in the skin microbiome. This meeting will provide a platform for crucial discussions which will hasten the development of microbiome-targeting therapeutics and cosmetics that focus on characterization, clinical testing, and product commercialization.

This is your opportunity to connect with 100+ collaborative thought leaders in the skin microbiome field from academics, drug developers, cosmeceutical developers, cosmetic and consumer brands, to obtain a holistic view of the microbiome dermatology landscape that will revolutionise your product pipeline.

Tickets    https://go.evvnt.com/1151883-2?pid=1052
Brochure https://go.evvnt.com/1151883-3?pid=1052

Prices:
Biotech & Pharma Pricing - Conference Only USD 2599.00
Biotech & Pharma Pricing - Conference + Bootcamp Day USD 3946.00
Solution & Service Provider Pricing - Conference Only USD 3199.00
Solution & Service Provider Pricing - Conference + Bootcamp Day USD 4846.00
Academic & Small Biotech Pricing - Conference Only USD 2199.00
Academic & Small Biotech Pricing - Conference + Bootcamp Day USD 3246.00

Category: Conferences | Science, Health & Medicine | Pharmaceuticals

Todd Kruegar, Founder & CEO, AOBiome, Hyun Kim, VP Clinical Operations, AOBiome Therapeutics, Julie O’Sullivan, Postdoctoral Researcher, APC Microbiome Ireland, Konstantinos Gardikis, R&D Director, Apivita, Dr. Brent Ridge, Founder, Beekman 1802, Erwan Peltier, Medical Manager Dermatology, Bayer, Joakim Annwell, Regional Director, BioGaia AB, Josh Kilmer-Purcell, Founder, Beekman 1802, Jörn Hendrik, Head of Microbiome Accelerator, Beiersdorf, Assaf Oron, CBO, BiomX, Cheri Ackerman, Co-Founder & CEO, Concerto Biosciences, Robert Brucker, Co-founder & CSO, DermBiont, Inc., Elsa Jungman, Ph.D. Founder & CEO, ELSI Skin Health, Fabien Havas, Senior R&D Project Manager, Active Ingredients, IFF Lucas Meyer, Marie Drago, Founder, Gallinée, Ahmad Khodr (Ph.D.), Head of the Microbiology Innovation Lab. and Microbiome projects Leader, L’Oréal R&I, Georgios Stamatas, PhD, Research Associate Director, Essential Health Translational Design, Johnson & Johnson, Shaun Demehri, Associate Professor, Department of Dermatology and Cancer Center, Massachusetts General Hospital, Harvard Medical School, Yug Varma, CEO, Phi Therapeutics, François Brillet, Skin Microbiome Scientist, S-Biomedic, Larry Weiss, CEO & Founder, Symbiome, Noga Qvit, CEO, TopgeniX, Dr Tiina Orasmäe-Meder, CEO and Founder, MEDER BEAUTY, Kristin Neumann, Founder & Author, MyMicrobiome, Joice Varma, CEO, Phi Therapeutics, Michael Hoptroff, Senior R&D Manager, Unilever, Samantha Samaras, PhD, FRSB Global VP Science and Technology Global VP Clinicals, Unilever, Matthew J. Bresnah, Partner, Wilson Sonsini, Mireille Vega, Business Development & Scientific Affairs, VGAM Biosciences, Inc.